ORLANDO, FL / ACCESS Newswire / April 20, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced that on-demand replays from its Biotech Resurgence: Platforms and Pipelines of Today's Innovators investor conference, held April 16, 2026, are now available.
The full-day virtual event featured senior executives from publicly traded companies advancing innovation across biotechnology, therapeutics, medical devices, diagnostics, and digital health. Investors who were unable to attend the live event-or who wish to revisit specific company presentations-can now access full video replays at their convenience.
"The strong engagement we saw throughout this conference-drawing nearly 100,000 viewers-highlights the continued investor focus on innovation across the healthcare sector," said Dave Gentry, CEO of RedChip Companies. "From clinical-stage drug development to scalable healthcare platforms, the presenting companies demonstrated the breadth of opportunity emerging across biotech and healthcare. By making these presentations available on demand, we are extending access to valuable insights into companies driving the next wave of healthcare innovation."
Conference Presentation Replays
Investors may view individual company presentations and Q&A sessions using the links below:
Kyntra Bio (Nasdaq:KYNB)
Anixa Biosciences (Nasdaq:ANIX)
GT Biopharma (Nasdaq:GTBP)
Additional presentation replays are available on RedChip's YouTube channel.
Each replay includes a management presentation followed by a live investor Q&A session, offering deeper insight into clinical development strategies, pipeline progress, commercialization pathways, and competitive positioning across the healthcare landscape.
The Biotech Resurgence conference was designed to provide institutional and retail investors with direct access to companies developing next-generation therapies, enabling technologies, and scalable healthcare solutions. As highlighted throughout the event, innovation across biotech and healthcare continues to accelerate, driven by advances in science, technology, and care delivery models.
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. Founded in 1992 as a small-cap research firm, RedChip gained early recognition for initiating coverage on emerging blue chip companies such as Apple, Starbucks, Daktronics, Winnebago, and Nike. Over the past 33 years, RedChip has evolved into a full-service investor relations and media firm, delivering concrete, measurable results for its clients, which have included U.S. Steel, Perfumania, Cidara Therapeutics, and Celsius Holdings, among others. Our newsletter, Small Stocks, Big Money, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
Sign Up for RedChat
RedChat is an AI-powered investment research assistant designed to give investors instant access to critical insights from SEC filings, press releases, and corporate disclosures. Built to streamline small-cap and microcap stock research, RedChat analyzes thousands of public company documents and delivers clear, context-rich answers to investor questions in seconds. Instead of manually reviewing lengthy filings, investors can simply ask RedChat about financial results, partnerships, business strategy, or recent announcements and receive precise, source-based summaries. Investors can experience RedChat and start exploring stocks today at www.redchip.com/stocks or www.red.chat.
To learn more about RedChip's products and services, please visit:
"Discovering Tomorrow's Blue Chips Today"
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest
Contact:
Dave Gentry
RedChip Companies Inc.
1-800-REDCHIP (733-2447)
1-407-644-4256
info@redchip.com
--END--
SOURCE: RedChip Companies, Inc.
View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/business-and-professional-services/replays-from-redchips-biotech-investor-conference-now-available-1158947
